Asia Pacific Female Infertility Diagnosis Market Size & Outlook
The female infertility diagnosis market in Asia Pacific is expected to reach a projected revenue of US$ 2,561.6 million by 2030. A compound annual growth rate of 8.9% is expected of Asia Pacific female infertility diagnosis market from 2024 to 2030.
Revenue, 2023 (US$M)
$1,408.8
Forecast, 2030 (US$M)
$2,561.6
CAGR, 2024 - 2030
8.9%
Report Coverage
Asia Pacific
Asia Pacific female infertility diagnosis market highlights
- The Asia Pacific female infertility diagnosis market generated a revenue of USD 1,408.8 million in 2023.
- The market is expected to grow at a CAGR of 8.9% from 2024 to 2030.
- In terms of segment, ovarian reserve testing was the largest revenue generating test in 2023.
- Ovarian reserve testing is the most lucrative test segment registering the fastest growth during the forecast period.
Asia Pacific data book summary
| Market revenue in 2023 | USD 1,408.8 million |
| Market revenue in 2030 | USD 2,561.6 million |
| Growth rate | 8.9% (CAGR from 2023 to 2030) |
| Largest segment | Ovarian reserve testing |
| Fastest growing segment | Ovarian reserve testing |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Ovarian reserve testing |
| Key market players worldwide | PFCLA, the mayo foundation, Cleveland Clinic, Apricity, Dallas IVF, Midwest Fertility Specialists, Europe IVF, Aspire Fertility, Nordic Capital |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 31.7% of the global female infertility diagnosis market in 2023.
- Globally, Europe is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 2,561.6 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Female Infertility Diagnosis Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Aspire Fertility | View profile | 11-50 | Houston, Texas, United States, North America | https://www.aspirefertility.com/ |
| Nordic Capital | View profile | 101-250 | Copenhagen, Hovedstaden, Denmark, Europe | http://www.nordiccapital.com |
| Europe IVF | View profile | 11-50 | Prague, Hlavni mesto Praha, Czech Republic, Europe | https://europeivf.com |
| Midwest Fertility Specialists | View profile | 51-100 | Carmel, Indiana, United States, North America | https://www.midwestfertility.com |
| Dallas IVF | View profile | 1-10 | Frisco, Texas, United States, North America | https://www.dallasivf.com |
| Apricity | View profile | 11-50 | Paris, Ile-de-France, France, Europe | https://www.apricity.life/ |
| Cleveland Clinic | View profile | 1001-5000 | Cleveland, Ohio, United States, North America | http://my.clevelandclinic.org |
| PFCLA | View profile | 101-250 | Los Angeles, California, United States, North America | https://www.pfcla.com/ |
| the mayo foundation | View profile | - | - |
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
